Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1390777 NEW YORK, NY
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$21,768,231
+$12,114,269 QoQ
Shares Held
245,193
+28.1% QoQ
Ownership
0.278%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 266 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. SYRE ranks #38 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in SYRE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,768,231 245,193
2026-03-31 $9,653,962 191,395
2025-12-31 $6,317,109 192,830
2025-09-30 $2,278,688 135,960
2025-06-30 $1,978,284 132,150
2025-03-31 $1,843,261 114,240
2024-12-31 $2,413,856 103,688
2024-09-30 $3,082,344 104,806
2024-06-30 $2,766,797 117,686
2024-03-31 $229,476 6,050